Advisory Committees
-
-
Recently Updated Advisory Committee Materials
-
-
Posted on February 28, 2012
Oncologic Drugs Advisory Committee
- Minutes for the February 9, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF - 71KB)
- 2012 Meeting Materials, Oncologic Drugs Advisory Committee
- Minutes for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF - 27KB)
Endocrinologic and Metabolic Drugs Advisory Committee
- Briefing Information for the July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee
- Errata (2) to the FDA Briefing Information for the July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (PDF – 9KB) (PDF - 8KB)
Advisory Committee Calendar
Nonprescription Drugs Advisory Committee
Anti-Infective Drugs Advisory Committee
Cardiovascular and Renal Drugs Advisory Committee
Advisory Committee Calendar
Pharmaceutical Science and Clinical Pharmacology Advisory Committee
- Vinks_Disclosure Document for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-14KB) (PDF - 19KB)
- Mager_Disclosure Document for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-14KB) (PDF - 19KB)
- 18 U.S.C. 208(a) and 712(c)(2)(B) Waivers for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-22KB) (PDF - 34KB)
- Capparelli_Disclosure Document for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-14KB) (PDF - 19KB)
- 18 U.S.C. 208(a) and 712(c)(2)(B) Waivers for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-157KB) (PDF - 168KB)
- Disclosure Document for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-14KB) (PDF - 19KB)
- Waivers for Conflicts of Interest for the March 14, 2012 Meeting of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology
- 18 U.S.C. 208(a) and 712(c)(2)(B) Waivers for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-263KB) (PDF - 266KB)
- 18 U.S.C. 208(a) and 712(c)(2)(B) Waivers for the March 14, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-249KB) (PDF - 252KB)
- 2012 Meeting Materials, Pharmaceutical Science and Clinical Pharmacology Advisory Committee
-
Posted on February 27, 2012
Advisory Committee Calendar
Gastrointestinal Drugs Advisory Committee
- Waivers for Conflicts of Interest for the March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee
- Disclosure Document for the March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-16KB) (PDF - 13KB)
- 18 U.S.C. 208(a) and 712(c)(2)(B) Waivers for the March 13, 2012 Meeting of the Gastrointestinal Drugs Advisory Committee (PDF-509KB) (PDF - 512KB)
-
Posted on February 24, 2012
Advisory Committee Calendar
-
Posted on February 23, 2012
Dermatologic and Ophthalmic Drugs Advisory Committee
- 2012 Meeting Materials, Dermatologic and Ophthalmic Drugs Advisory Committee
- Committee Roster for the February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (PDF - 20KB)
- Draft Meeting Roster for the February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (PDF - 29KB)
- Draft Questions for the February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (PDF - 19KB)
- Draft Agenda for the February 27, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (PDF - 18KB)
Nonprescription Drugs Advisory Committee
Peripheral and Central Nervous System Drugs Advisory Committee
-
Posted on February 21, 2012
Oncologic Drugs Advisory Committee
- Webcast Information for the February 9, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF - 29KB)
- Webcast Information for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF - 28KB)
- Slides for the February 9, 2012 Meeting of the Oncologic Drugs Advisory Committee
- Eisai Backup Presentations for the February 9, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 237KB) (PDF - 237KB)
- Eisai Main Presentations for the February 9, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 1.13MB) (PDF - 1.1MB)
- FDA Backup Presentations for the February 9, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 19KB) (PDF - 18KB)
- FDA Main Presentations for the February 9, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 539KB) (PDF - 273KB)
- Final Meeting Roster for the February 9, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF - 19KB)
- Final Questions for the February 9, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF - 42KB)
- Final Agenda for the February 9, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF - 17KB)
- Slides for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee
- Amgen Presentations for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 1.52MB) (PDF - 1.5MB)
- FDA Backup Presentations for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 18KB) (PDF - 14KB)
- FDA Main Presentations for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 548KB) (PDF - 516KB)
- Final Meeting Roster for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF - 17KB)
- Final Questions for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF - 15KB)
- Final Agenda for the February 8, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF - 15KB)
Cardiovascular and Renal Drugs Advisory Committee
-
-
-
-







